Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Effectiveness of silymarin with lifestyle intervention in NAFLD and metabolic syndrome: a prospective single-arm study
Drugs in Context
2026
Sukeepaisarnjaroen W.
Open Access
Silymarin for adults with metabolic dysfunction-associated steatotic liver disease
Cochrane Database of Systematic Reviews
24 June 2025
Wang C.
All Open Access, Green
Historical insights of polyphenols in human health
Bioactive Polyphenols for Health and Pathology Treatment
1 January 2025
Quero J.
Impacts of Supplementation with Silymarin on Cardiovascular Risk Factors: A Systematic Review and Dose–Response Meta-Analysis
Antioxidants
April 2024
Mohammadi S.
Open Access
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis
Annals of Hepatology
1 March 2024
Li S.
Open Access
Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
Canadian Liver Journal
February 2024
Malik A.
All Open Access, Green
Efficacy of silymarin in patients with non-alcoholic fatty liver disease — the Siliver trial: a study protocol for a randomized controlled clinical trial
Trials
December 2023
de Avelar C.R.
Open Access
Silymarin treatment and reduction of liver enzyme levels in non-alcoholic fatty liver disease: a case report
Drugs in Context
2023
Chantarojanasiri T.
Open Access
Silymarin and management of liver function in nonalcoholic steatohepatitis: a case report
Drugs in Context
2023
Hashem A.
Open Access
Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
Scientia Pharmaceutica
2023
Nucera S.
Open Access
Role of silymarin in the management of deranged liver function in non-alcoholic steatohepatitis: a case report
Drugs in Context
2023
Lee Y.Y.
Open Access
Effect of medicinal plants and natural products on liver enzymes in non-alcoholic fatty liver patients in iran: A systematic review and meta-analysis
International Journal of Preventive Medicine
1 January 2022
Fakhri M.
The Effects of Vitamin E, Silymarin and Carnitine on the Metabolic Abnormalities Associated with Nonalcoholic Liver Disease
Journal of Dietary Supplements
2022
Poulos J.E.
Effect of silymarin on liver size and nonalcoholic fatty liver disease in morbidly obese patients: A randomized double-blind clinical trial
Journal of Research in Medical Sciences
1 January 2022
Atarodi H.
Open Access
Antioxidative effects of silymarin on the reduction of liver complications of fingolimod in patients with relapsing–remitting multiple sclerosis: A clinical trial study
Journal of Biochemical and Molecular Toxicology
August 2021
Ghiasian M.
Nano- and Microsized Forms of Silymarin and Silybin
Nanobiotechnology Reports
March 2021
Poltavets Y.I.
NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
Canadian Journal of Gastroenterology and Hepatology
2021
Marušić M.
Open Access
Silymarin in combination with vitamin C, vitamin E, coenzyme q10 and selenomethionine to improve liver enzymes and blood lipid profile in NAFLD patients
Medicina Lithuania
October 2020
Curcio A.
Open Access
The effects of realsil (Silybin–phospholipid–vitamin e complex) on liver enzymes in patients with non-alcoholic fatty liver disease (nafld) or nonalcoholic steato-hepatitis (nash): A systematic review and meta-analysis of rcts
Acta Endocrinologica
April - June 2020
Derakhshandeh-Rishehri S.M.
All Open Access, Green
Role of silymarin in the management of non-alcoholic fatty liver disease: Time to clear the mist
Bioactive Compounds in Health and Disease
May 2019
Roy K.
Open Access
Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases
Phytotherapy Research
November 2018
Abenavoli L.
Effect of livergol on the improvement of fatty liver in patients with cancer undergoing irinotecan- and oxaliplatin-based chemotherapy regimen
Journal of Research in Medical Sciences
1 January 2018
Emami H.
Open Access
The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials
Medicine United States
1 December 2017
Zhong S.
Open Access
Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis
World Journal of Gastroenterology
21 July 2017
De Avelar C.R.
Open Access